© 2000 American Heart Association, Inc.
Atherosclerosis and Lipoproteins |
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis
The Atherosclerosis and Insulin Resistance (AIR) Study
From the Wallenberg Laboratory for Cardiovascular Research (J.H., J.W.) and the Department of Medicine (L.B., B.F.), Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden.
Correspondence to Johannes Hulthe, MD, PhD, the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden. E-mail johannes.hulthe{at}wlab.wall.gu.se
Abstract—An operative definition of the metabolic syndrome has been suggested by a working group associated with the World Health Organization in 1998. The aim of this study was to examine whether small, low density lipoprotein (LDL) particle size was associated with the metabolic syndrome and with subclinical atherosclerosis as measured by ultrasound in the carotid and femoral arteries. The study was performed in a population-based sample of clinically healthy men (N=391), all 58 years old and not undergoing any treatment with cardiovascular drugs. Exclusion criteria were cardiovascular or other clinically overt diseases or continuous medication with cardiovascular drugs. The results showed that subjects characterized by the metabolic syndrome (n=62) had a thicker mean intima-media complex (IMT) in both the carotid and femoral arteries (0.86 versus 0.77 mm, P<0.001, and 1.03 versus 1.00 mm, P=0.022, respectively) and also lower mean values for LDL particle size (25.78 versus 26.80 nm, respectively, P<0.001) compared with subjects with no risk factors (n=77). The group with the metabolic syndrome (n=62) also had higher mean values for serum cholesterol and heart rate. In the whole study group (N=391), there were significant but weak negative relationships between small LDL particle size, increasing IMT, and increasing cross-sectional intima-media area of the carotid and femoral arteries and also negative relationships between LDL particle size and plaque occurrence and size in the carotid and femoral arteries. In summary, this is the first large-scale study to demonstrate a relationship between the clustering of risk factors that constitute the metabolic syndrome and a small LDL particle size pattern and the occurrence of preclinical atherosclerosis in the carotid and femoral arteries, as assessed by the ultrasound technique, in healthy 58-year-old men recruited from the general population.
Key Words: metabolic syndrome • atherosclerosis • ultrasound • LDL particle size
This article has been cited by other articles:
 |
|
 |
|
  A. M.J. Wassink, Y. van der Graaf, J. K. Olijhoek, F. L.J. Visseren, and for the SMART Study Group Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm Eur. Heart J., January 2, 2008; 29(2): 213 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Rosenson, D. A. Wolff, A. L. Huskin, I. B. Helenowski, and A. W. Rademaker Fenofibrate Therapy Ameliorates Fasting and Postprandial Lipoproteinemia, Oxidative Stress, and the Inflammatory Response in Subjects With Hypertriglyceridemia and the Metabolic Syndrome Diabetes Care, August 1, 2007; 30(8): 1945 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bosevski, V. Borozanov, and L. Georgievska-Ismail Influence of metabolic risk factors on the presence of carotid artery disease in patients with type 2 diabetes and coronary artery disease Diabetes and Vascular Disease Research, March 1, 2007; 4(1): 49 - 52. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-P. Empana, M. Zureik, J. Gariepy, D. Courbon, J. F. Dartigues, K. Ritchie, C. Tzourio, A. Alperovitch, and P. Ducimetiere The Metabolic Syndrome and the Carotid Artery Structure in Noninstitutionalized Elderly Subjects: The Three-City Study Stroke, March 1, 2007; 38(3): 893 - 899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Friedlander, J. Weinreb, I. Friedlander, and J. A. Yagiela Metabolic syndrome: Pathogenesis, medical care and dental implications J Am Dent Assoc, February 1, 2007; 138(2): 179 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tivesten, J. Hulthe, K. Wallenfeldt, J. Wikstrand, C. Ohlsson, and B. Fagerberg Circulating Estradiol Is an Independent Predictor of Progression of Carotid Artery Intima-Media Thickness in Middle-Aged Men J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4433 - 4437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hassinen, P. Komulainen, T. A. Lakka, S. B. Vaisanen, I. Haapala, H. Gylling, M. Alen, A. Schmidt-Trucksass, A. Nissinen, and R. Rauramaa Metabolic syndrome and the progression of carotid intima-media thickness in elderly women. Arch Intern Med, February 27, 2006; 166(4): 444 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rizzo and K. Berneis Low-density lipoprotein size and cardiovascular risk assessment QJM, January 1, 2006; 99(1): 1 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Davidsson, J. Hulthe, B. Fagerberg, B.-M. Olsson, C. Hallberg, B. Dahllof, and G. Camejo A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes J. Lipid Res., September 1, 2005; 46(9): 1999 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Tzou, P. S. Douglas, S. R. Srinivasan, M. G. Bond, R. Tang, W. Chen, G. S. Berenson, and J. H. Stein Increased Subclinical Atherosclerosis in Young Adults With Metabolic Syndrome: The Bogalusa Heart Study J. Am. Coll. Cardiol., August 2, 2005; 46(3): 457 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stan, E. Levy, E. E. Delvin, J. A. Hanley, B. Lamarche, J. O'Loughlin, G. Paradis, and M. Lambert Distribution of LDL Particle Size in a Population-Based Sample of Children and Adolescents and Relationship with Other Cardiovascular Risk Factors Clin. Chem., July 1, 2005; 51(7): 1192 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takamiya, W. R. Zaky, D. Edmundowics, T. Kadowaki, H. Ueshima, L. H. Kuller, and A. Sekikawa World Health Organization-Defined Metabolic Syndrome Is a Better Predictor of Coronary Calcium Than the Adult Treatment Panel III Criteria in American Men Aged 40-49 Years Diabetes Care, December 1, 2004; 27(12): 2977 - 2979. [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Lee, M.-T. Huang, W. Wang, C.-M. Lin, T.-C. Chen, and I-R. Lai Effects of Obesity Surgery on the Metabolic Syndrome Arch Surg, October 1, 2004; 139(10): 1088 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wallenfeldt, L. Bokemark, J. Wikstrand, J. Hulthe, and B. Fagerberg Apolipoprotein B/Apolipoprotein A-I in Relation to the Metabolic Syndrome and Change in Carotid Artery Intima-Media Thickness During 3 Years in Middle-Aged Men Stroke, October 1, 2004; 35(10): 2248 - 2252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sjogren, M. Rosell, C. Skoglund-Andersson, S. Zdravkovic, B. Vessby, U. de Faire, A. Hamsten, M.-L. Hellenius, and R. M. Fisher Milk-Derived Fatty Acids Are Associated with a More Favorable LDL Particle Size Distribution in Healthy Men J. Nutr., July 1, 2004; 134(7): 1729 - 1735. [Abstract] [Full Text]
|
|
|
|
|
|
T. Teerlink, P. G. Scheffer, S. J. L. Bakker, and R. J. Heine Combined data from LDL composition and size measurement are compatible with a discoid particle shape J. Lipid Res., May 1, 2004; 45(5): 954 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Scuteri, S. S. Najjar, D. C. Muller, R. Andres, H. Hougaku, E. J. Metter, and E. G. Lakatta Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness J. Am. Coll. Cardiol., April 21, 2004; 43(8): 1388 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Prabhakaran and S. S Anand The metabolic syndrome: an emerging risk state for cardiovascular disease Vascular Medicine, February 1, 2004; 9(1): 55 - 68. [Abstract] [PDF]
|
|
|
|
|
|
O. Olivieri, A. Bassi, C. Stranieri, E. Trabetti, N. Martinelli, F. Pizzolo, D. Girelli, S. Friso, P. F. Pignatti, and R. Corrocher Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease J. Lipid Res., December 1, 2003; 44(12): 2374 - 2381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J.G. Hanley, L. E. Wagenknecht, R. B. D'Agostino Jr., B. Zinman, and S. M. Haffner Identification of Subjects with Insulin Resistance and {beta}-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome Diabetes, November 1, 2003; 52(11): 2740 - 2747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Anand, Q. Yi, H. Gerstein, E. Lonn, R. Jacobs, V. Vuksan, K. Teo, B. Davis, P. Montague, and S. Yusuf Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease Circulation, July 29, 2003; 108(4): 420 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Fried, M. G. Shlipak, C. Crump, A. J. Bleyer, J. S. Gottdiener, R. A. Kronmal, L. H. Kuller, and A. B. Newman Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1364 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ishizaka, Y. Ishizaka, E. Takahashi, T. Unuma, E.-i. Tooda, R. Nagai, M. Togo, K. Tsukamoto, H. Hashimoto, and M. Yamakado Association Between Insulin Resistance and Carotid Arteriosclerosis in Subjects With Normal Fasting Glucose and Normal Glucose Tolerance Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 295 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, J. D. Best, and L. J. Beilin Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients Diabetes Care, January 1, 2003; 26(1): 253 - 253. [Full Text] [PDF]
|
|
|
|
|
|
J. Hulthe and B. Fagerberg Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1162 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Yatsu and J. D. Morrisett Carotid Intima-Media Thickness in Familial Combined Hyperlipidemia and LDL Size Stroke, May 1, 2002; 33(5): 1174 - 1175. [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Liu, K. Ylitalo, I. Nuotio, R. Salonen, J. T. Salonen, and M.-R. Taskinen Association Between Carotid Intima-Media Thickness and Low-Density Lipoprotein Size and Susceptibility of Low-Density Lipoprotein to Oxidation in Asymptomatic Members of Familial Combined Hyperlipidemia Families Stroke, May 1, 2002; 33(5): 1255 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Ford, W. H. Giles, and W. H. Dietz Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey JAMA, January 16, 2002; 287(3): 356 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gotto Jr and L. H. Kuller Eligibility for Lipid-Lowering Drug Therapy in Primary Prevention: How Do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines Compare? Circulation, January 15, 2002; 105(2): 136 - 139. [Full Text] [PDF]
|
|
|
|
|
|
J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men Arterioscler Thromb Vasc Biol, January 1, 2001; 21(1): 101 - 107. [Abstract] [Full Text] [PDF]
|
|